Edith Salot Harris

Title: Innovations of Edith Salot Harris

Introduction

Edith Salot Harris is a notable inventor based in Seattle, WA. She has made significant contributions to the field of biotechnology, particularly in the area of integrin binding and signaling. With a total of 2 patents, her work has implications for understanding cellular interactions and developing therapeutic strategies.

Latest Patents

Her latest patents include "Cytoplasmic Modulators of Integrin Binding/Signalling." This invention relates to purified and isolated polynucleotides that encode a polypeptide specifically binding to a cytoplasmic portion of an integrin. The invention provides a FLP-1-encoding polynucleotide and the polypeptide product of the gene. Additionally, it includes expression vectors comprising the polynucleotide, antibodies that recognize the polypeptide, hybridomas that secrete the antibodies, and methods to identify modulators of the interaction of the polypeptide with β7 subunit sequences. Another patent focuses on methods to identify modulators of integrin binding and/or signaling activity, specifically targeting compounds that can alter the interaction between the cytoplasmic domain of a β1 integrin and a proteasome subunit protein.

Career Highlights

Edith has had a distinguished career, working at Icos Corporation, where she has been able to apply her innovative ideas in a collaborative environment. Her research has contributed to advancements in understanding integrin functions, which are crucial for various biological processes.

Collaborations

One of her notable collaborators is Donald E. Staunton. Their partnership has fostered a productive research atmosphere, leading to significant advancements in their field.

Conclusion

Edith Salot Harris exemplifies the spirit of innovation in biotechnology through her patents and research contributions. Her work continues to influence the understanding of integrin signaling and its potential therapeutic applications.